What the clinical trial evidence shows Mounjaro (tirzepatide) ~22.5% average body weight lost at 72 weeks ( SURMOUNT-1, 15mg) Wegovy (semaglutide) ~14.9% average body weight lost at 68 weeks ( STEP-1 , 2.4mg) Saxenda / Nevolat (liraglutide) ~5-8% average body weight lost at 56 weeks ( SCALE trial ) For context, prior to GLP-1 medications, the most effective non-surgical weight loss intervention available was a combination of intensive lifestyle modification and Orlistat , which typically produces 5 to 8% weight loss
Gonadorelin and kisspeptin rank next because they sit upstream of LH and FSH signaling, but they are not simple over-the-counter testosterone boosters
Growth hormone response was 5065% lower than fasted pre-sleep dosing, not because the peptides were inactive, but because somatostatin tone and insulin interference blocked receptor signaling
For muscle growth and recovery, the combination addresses the full regenerative pathway
Schedule your first glutathione push with IV Elements Ready to enhance your wellness journey with an in-lounge or mobile glutathione push in NJ, NYC, or PA